Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy P Cripe

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Molecular Therapy Oncolytics|January 1, 2020
GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal SurvivalPaola Sette, Nduka Amankulor, Aofei Li, et al.
Molecular Therapy Oncolytics|December 4, 2018
Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune MicroenvironmentNicholas L Denton, Chun-Yu Chen, Brian Hutzen, et al.
Molecular Therapy. Oncology|February 3, 2025
Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastomaYaya Chu, Meijuan Tian, Uksha Saini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2012
Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic targetAmi V Patel, David Eaves, Walter J Jessen, et al.
Molecular Therapy. Oncology|November 18, 2024
Combinatorial immunotherapy of anti-MCAM CAR-modified expanded natural killer cells and NKTR-255 against neuroblastomaWen Luo, Aliza Gardenswartz, Hai Hoang, et al.
Cancer Research Communications|June 22, 2026
Phase 1 study of oncolytic virus VV1 as monotherapy or in combination with avelumab in patients with relapsed refractory solid tumorsJaime R Merchan, Manish R Patel, Timothy P Cripe, et al.
Cancer Research|October 11, 2017
A Collaborative Model for Accelerating the Discovery and Translation of Cancer TherapiesOphélia Maertens, Mila E McCurrach, Benjamin S Braun, et al.
Cancers|June 19, 2024
Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric PatientsRituraj Upadhyay, Brett Klamer, Jennifer Matsui, et al.
Molecular Therapy Oncolytics|October 6, 2015
Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in childrenGregory K Friedman, Elizabeth A Beierle, George Yancey Gillespie, et al.
Molecular Therapy Oncolytics|October 6, 2015
Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in childrenTimothy P Cripe, Chun-Yu Chen, Nicholas L Denton, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Molecular Therapy Oncolytics|January 1, 2020
GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal SurvivalPaola Sette, Nduka Amankulor, Aofei Li, et al.
Molecular Therapy Oncolytics|December 4, 2018
Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune MicroenvironmentNicholas L Denton, Chun-Yu Chen, Brian Hutzen, et al.
Molecular Therapy. Oncology|February 3, 2025
Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastomaYaya Chu, Meijuan Tian, Uksha Saini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2012
Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic targetAmi V Patel, David Eaves, Walter J Jessen, et al.
Molecular Therapy. Oncology|November 18, 2024
Combinatorial immunotherapy of anti-MCAM CAR-modified expanded natural killer cells and NKTR-255 against neuroblastomaWen Luo, Aliza Gardenswartz, Hai Hoang, et al.
Cancer Research Communications|June 22, 2026
Phase 1 study of oncolytic virus VV1 as monotherapy or in combination with avelumab in patients with relapsed refractory solid tumorsJaime R Merchan, Manish R Patel, Timothy P Cripe, et al.
Cancer Research|October 11, 2017
A Collaborative Model for Accelerating the Discovery and Translation of Cancer TherapiesOphélia Maertens, Mila E McCurrach, Benjamin S Braun, et al.
Cancers|June 19, 2024
Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric PatientsRituraj Upadhyay, Brett Klamer, Jennifer Matsui, et al.
Molecular Therapy Oncolytics|October 6, 2015
Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in childrenGregory K Friedman, Elizabeth A Beierle, George Yancey Gillespie, et al.
Molecular Therapy Oncolytics|October 6, 2015
Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in childrenTimothy P Cripe, Chun-Yu Chen, Nicholas L Denton, et al.
Pageof 13